OMIM Search - '+cs_neurologic:("mental retardation" OR "cognitive impairment" OR "intellectual impairment" OR "impaired intellectual development" OR "intellectual disability" OR "mentally retarded" OR "cognitive delay" OR "Delayed intellectual development" OR "Delayed cognitive development" OR "Cognitive deficits" OR "Mental deficiency" OR "intellectual decline" OR "Cognitive dysfunction" OR "Cognitive decline" OR "Cognitive function loss" OR "Cognitive defects" OR "Cognitive deterioration" OR "Cognitive regression" OR "Cognitive disability" OR "Cognitive development may be significantly impaired or normal" OR "Impaired cognitive development" OR "No cognitive development" OR "Intellectual developmental impairment" OR "Intellectual deterioration" OR "Intellectual delay" OR "Impaired or absent intellectual development" OR "Intellectual developmental deficit" OR "Mental deterioration" OR "Mental lethargy" OR "Mental impairment" OR "Mental delay or retardation" OR "Retarded mental development" OR "Progressive mental and motor deterioration" OR "Mental and motor retardation") (Search in: Prefixes: #, Chromosomes: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)'
Downloaded:	Nov 17, 2020
Copyright (c) 1966-2020 Johns Hopkins University OMIM, data are provided for research purposes only.

MIM Number	Title	Included Titles	Cytogenetic Location	Genomic Coordinates (From NCBI/GRCh38)	Entrez Gene ID
#618242	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21		14q12		
#268800	SANDHOFF DISEASE	SANDHOFF DISEASE, ADULT TYPE, INCLUDED	5q13.3		
#214500	CHEDIAK-HIGASHI SYNDROME; CHS		1q42.3		
#618476	BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS		5q32		
#617145	NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET; NADGP		5q35.3		
#613647	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48		7p22.1		
#601367	STROKE, ISCHEMIC		1q24.2, 7q36.1, 11p11.2, 13q12.3, 14q23.1		
#618342	INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS		7q22.3		
#613735	BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	CHROMOSOME 1p32-p31 DELETION SYNDROME, INCLUDED	1p31.3		
#270700	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15		14q24.1		
#104290	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1		1q23.2		
#182601	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4		2p22.3		
#241080	WOODHOUSE-SAKATI SYNDROME; WDSKS		2q31.1		
#256730	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1	NEURONAL CEROID LIPOFUSCINOSIS, INFANTILE, INCLUDED; INCL, INCLUDED	1p34.2		
#613002	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2		4q35.1		
#610127	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10	NEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	11p15.5		
#613925	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A		11q24.2		
#614409	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46		9p13.3		
#604360	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11		15q21.1		
#617808	COFFIN-SIRIS SYNDROME 6; CSS6		12q12		
#238700	HYPERLYSINEMIA, TYPE I		7q31.32		
#256731	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5	NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED	13q22.3		
#607454	SPINOCEREBELLAR ATAXIA 21; SCA21		1p36.33		
#615528	PARKINSON DISEASE 19A, JUVENILE-ONSET; PARK19A	PARKINSON DISEASE 19B, EARLY-ONSET, INCLUDED; PARK19B, INCLUDED	1p31.3		
#615985	BARDET-BIEDL SYNDROME 8; BBS8		14q31.3		
#615993	BARDET-BIEDL SYNDROME 16; BBS16		1q43-q44		
#208400	ASPARTYLGLUCOSAMINURIA; AGU		4q34.3		
#607014	HURLER SYNDROME		4p16.3		
#610003	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT		8p23.3		
#616739	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51; MRT51		2q22.1		
#233400	PERRAULT SYNDROME 1; PRLTS1		5q23.1		
#618663	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81; DEE81		15q21.2		
#615035	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55		12q24.31		
#615889	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP		6p21.1		
#235400	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1	HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	1q31.3, 1q31.3, 1q31.3		
#613707	LEOPARD SYNDROME 3; LPRD3		7q34		
#221820	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS; HDLS		5q32		
#168601	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	ATYPICAL PARKINSON DISEASE, INCLUDED	4q22.1		
#600795	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3		3p11.2		
#604218	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB		3q26.1		
#236690	HYDROCEPHALUS, NORMAL-PRESSURE, 1; HYDNP1		10q25.1		
#248900	MAST SYNDROME		15q22.31		
#249900	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY		10q22.1		
#254900	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4		4q21.1		
#272750	GM2-GANGLIOSIDOSIS, AB VARIANT		5q33.1		
#606693	KUFOR-RAKEB SYNDROME; KRS		1p36.13		
#607060	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8		12q12		
#609260	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A		1p36.22		
#610475	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2		2q31.2		
#610951	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7		4q28.2		
#615362	CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13		11q13.2		
#615924	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD		11q12.3		
#616187	EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7		11p15.1		
#616672	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27		13q34		
#616840	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23		15q22.2		
#617225	SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78		1p36.13		
#617575	NEPHROTIC SYNDROME, TYPE 14; NPHS14		10q22.1		
#617900	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8		12q14.2		
#618317	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7		9p13.3		
#618369	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27		1p12		
#618418	SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80		9p13.3		
#618868	NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE; CONATOC		9q31.1-q31.2		
#618221	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66		12p13.32		
#230350	GALACTOSEMIA III; GALAC3		1p36.11		
#611936	CHROMOSOME 3q29 DUPLICATION SYNDROME		3q29	3:192600000-198295559	
#610031	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7		6p25.2		
#126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED	2q37.3, 6p21.32, 6p21.32		
#164500	SPINOCEREBELLAR ATAXIA 7; SCA7		3p14.1		
#604187	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10		12q13.3		
#615191	LISSENCEPHALY 5; LIS5		7q31.1		
#213200	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2		9q34.3		
#600151	BARDET-BIEDL SYNDROME 3; BBS3		3q11.2		
#600462	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1		12q24.33		
#601390	VAN MALDERGEM SYNDROME 1; VMLDS1		11p15.4		
#601803	PALLISTER-KILLIAN SYNDROME; PKS	HEXASOMY 12p, MOSAIC, INCLUDED	12p		
#613406	WITTEVEEN-KOLK SYNDROME; WITKOS	CHROMOSOME 15q24 DELETION SYNDROME, INCLUDED	15q24.2		
#614207	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3		11p15.4		
#614381	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8		12q23.3		
#614756	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR		1p36.31-p36.23		
#615546	VAN MALDERGEM SYNDROME 2; VMLDS2		4q28.1		
#617090	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17		12q24.23		
#617391	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54; DEE54		1q44		
#603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILURE, INCLUDED	1p34.1, 2p23.3, 3q27.1, 12q24.31, 14q24.3		
#611105	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL		1q25.1		
#613706	NOONAN SYNDROME 7; NS7		7q34		
#616192	ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD		13q32.1		
#618049	PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2		10q25.3		
#222700	LYSINURIC PROTEIN INTOLERANCE; LPI		14q11.2		
#607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7		10q22.3		
#231000	GAUCHER DISEASE, TYPE III; GD3	GAUCHER DISEASE, TYPE IIIA, INCLUDED	1q22		
#220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1; MC4DN1		9q34.2		
#150550	PERIODIC FEVER, IMMUNODEFICIENCY, AND THROMBOCYTOPENIA SYNDROME; PFITS		4p16.1		
#213000	CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY; CHEGDD		8q23.1		
#601224	POTOCKI-SHAFFER SYNDROME		11p11.2	11:43400000-48800000	
#601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS	BOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	7p15.2		
#603736	OHDO SYNDROME, SBBYS VARIANT; SBBYSS		10q22.2		
#226960	LOWRY-WOOD SYNDROME; LWS		2q14.2		
#606053	INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS		2q24.2		
#606220	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS		13q22.3		
#607208	DRAVET SYNDROME; DRVT		2q24.3		
#612164	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4; DEE4		9q34.11		
#613721	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11; DEE11		2q24.3		
#614306	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT		12q13.13		
#615074	GAND SYNDROME; GAND		1q21.3		
#615705	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15		3q29		
#615828	VULTO-VAN SILFHOUT-DE VRIES SYNDROME; VSVS		11p15.5		
#616239	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24		11q14.1		
#616682	SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS		11p11.2		
#617020	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38; DEE38		1q42.2		
#617171	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES; NEDHELS		11p15.5		
#618135	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8		3p22.1		
#618141	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67		12q24.11-q24.12		
#618147	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	CHROMOSOME 14q32 DELETION SYNDROME, INCLUDED	14q32.2		
#618158	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD		11q13.5-q14.1		
#618170	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS		1p34.3		
#618179	MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24		12q23.2		
#618198	MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24		15q23		
#618218	BAKER-GORDON SYNDROME; BAGOS		12q21.2		
#618226	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5		2q33.3		
#618234	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11		15q15.1		
#618248	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27		15q22.31		
#618276	NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA		9q21.33		
#618284	MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS		11p14.1		
#618285	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69		1q25.3		
#618291	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B		9q22.31		
#618292	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA		3p21.2		
#618295	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67		11p15.4		
#618298	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70		6p24.1		
#618325	LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9		1p34.3		
#618343	POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV		2q32.2		
#618348	GALLOWAY-MOWAT SYNDROME 7; GAMOS7		12q15		
#618349	GALLOWAY-MOWAT SYNDROME 8; GAMOS8		1q42.13		
#618351	MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25		7q22.1		
#618354	NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA		5q31.1		
#618356	NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD		1q32.1		
#618357	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15		9q21.13		
#618362	COFFIN-SIRIS SYNDROME 8; CSS8		12q13.2		
#618363	SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS		4q31.22		
#618378	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38		1q25.1		
#618381	FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG		11q13.1		
#618383	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69		3q12.3		
#618387	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3		1p32.3		
#618396	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74		5q34		
#618404	LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18		1q42.11		
#618425	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM		2q35		
#618437	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75		1p32.3		
#618438	SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9		15q15.1		
#618451	NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA		15q25.1		
#618453	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA		7p22.1		
#618454	DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA		7q22.1		
#618460	KHAN-KHAN-KATSANIS SYNDROME; 3KS		7q36.3		
#618468	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 76; EIEE76		7q22.1		
#618470	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD		7q22.1		
#618482	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10		5p12		
#618484	ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE; AMC3		6q25.2		
#618492	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA		2q31.1		
#618494	CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA		12p13.31		
#618504	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71		11q22.3		
#618512	O'DONNELL-LURIA-RODAN SYNDROME; ODLURO		7q22.3		
#618522	INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59		10q22.2		
#618547	NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA		10q22.1		
#618557	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 78; EIEE78		4p12		
#618569	NEURODEVELOPMENTAL DISORDER WITH ATAXIA, HYPOTONIA, AND MICROCEPHALY; NEDAHM		1p34.2		
#618571	NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES; NDCAGF		7p22.3		
#618572	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR HYPOPLASIA AND SPASTICITY; NEDCHS		8q22.1		
#618580	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80; DEE80		15q21.3		
#618587	INTELLECTUAL DEVELOPMENTAL DISORDER 60 WITH SEIZURES; MRD60		3q27.1		
#618604	SNIJDERS BLOK-FISHER SYNDROME; SNIBFIS		2q12.1		
#618606	PONTOCEREBELLAR HYPOPLASIA, TYPE 13; PCH13		11q13.1		
#618608	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES; IDNADFS	CHROMOSOME 12q15 DELETION SYNDROME, INCLUDED	12q15		
#618619	WEISS-KRUSZKA SYNDROME; WSKA		9q31.2		
#618622	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES; NEDMABA		2q21.1		
#618646	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2; DMJDS2		4q12		
#618651	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA, OPTIC ATROPHY, SEIZURES, AND STRUCTURAL BRAIN ANOMALIES; NEDSOSB		4q21.22		
#618653	INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES; IDDILF		11q23.3		
#618659	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES; NEDDFSA		10q22.3		
#618665	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72; MRT72		2q31.1		
#618687	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES; IDDSSBA		3p25.2-p25.1		
#618707	NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES; NEDALVS		6q21		
#618709	NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS		6q27		
#618718	NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES, ABSENT SPEECH, AND HYPOTONIA; NEDBASH		9q34.13		
#618724	HEYN-SPROUL-JACKSON SYNDROME; HESJAS		2p23.3		
#618729	LIANG-WANG SYNDROME; LIWAS		10q22.3		
#618730	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY; NEDMCMS		11q12.1		
#618732	POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS		6p21.33		
#618736	STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS; BAIDCS		3q24		
#618737	PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES; PAMDDFS		10q26.3		
#618748	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES; IDDHBA		13q12.13		
#618752	NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8		14q13.2		
#618768	SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81		2p23.3		
#618779	COFFIN-SIRIS SYNDROME 11; CSS11		12q13.12		
#618792	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84; DEE84		4p14		
#618798	BECK-FAHRNER SYNDROME; BEFAHRS		2p13.1		
#618800	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28; SCAR28		5q33.3		
#618808	INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA		9q34.3		
#618825	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY; MRD63		5p15.2		
#618830	AUTISM, SUSCEPTIBILITY TO, 20; AUTS20		3q26.31		
#618872	NIZON-ISIDOR SYNDROME; NIZIDS		3q25.1		
#618873	LISSENCEPHALY 10; LIS10		6q22.31		
#618879	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES; NEDHCAS		1p31.1		
#618885	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt; CDG2T		1q42.13		
#618890	NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY; NEDBASS		3p21.31		
#618917	NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB		4q32.1		
#618918	PERIVENTRICULAR NODULAR HETEROTOPIA 9; PVNH9		5q13.2		
#618922	NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES; NEDSHBA		3p26.1		
#618924	EPISODIC ATAXIA, TYPE 9; EA9		2q24.3		
#618958	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 47; COXPD47		8q21.13		
#618971	TOLCHIN-LE CAIGNEC SYNDROME; TOLCAS		11p15.2		
#618992	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 15; MDDGB15		1q22		
#619000	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEIZURES AND LANGUAGE DELAY; IDDSELD		12q24.31		
#619004	DEEAH SYNDROME; DEEAH		11p11.2		
#619005	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA; NEDDISH		11p11.2		
#619026	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA		1p34.1		
#619028	COENZYME Q10 DEFICIENCY, PRIMARY, 9; COQ10D9		12q24.31		
#619059	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15		11q13.1		
#117360	SPINOCEREBELLAR ATAXIA 29; SCA29		3p26.1		
#146500	MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	AUTONOMIC FAILURE, PURE, INCLUDED	4q21.23		
#164400	SPINOCEREBELLAR ATAXIA 1; SCA1		6p22.3		
#169500	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD		5q23.2		
#600224	SPINOCEREBELLAR ATAXIA 5; SCA5		11q13.2		
#601042	DYSTONIA 9; DYT9		1p34.2		
#602099	AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5		15q21.1		
#603472	NEURONAL INTRANUCLEAR INCLUSION DISEASE; NIID		1q21.2		
#250950	3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1		9q22.31		
#252011	MITOCHONDRIAL COMPLEX II DEFICIENCY		5p15.33, 11q23.1, 19q13.12		
#263570	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN		3p12.2		
#270750	SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE; SPG23		1q32.1		
#270800	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A		8q12.3		
#607346	SPINOCEREBELLAR ATAXIA 19; SCA19		1p13.2		
#607459	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	SPINOCEREBELLAR ATAXIA WITH EPILEPSY, INCLUDED; SCAE, INCLUDED	15q26.1		
#607876	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2		2q11.2		
#612067	DYSTONIA 16; DYT16		2q31.2		
#612126	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2		1p34.2		
#613204	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY		12q13.2		
#613206	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44		1q42.13		
#609583	JOUBERT SYNDROME 4; JBTS4		2q13		
#610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT; SPG30	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE, INCLUDED	2q37.3		
#610505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3		12q14.1		
#610733	NOONAN SYNDROME 4; NS4		2p22.1		
#610759	CORNELIA DE LANGE SYNDROME 3 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; CDLS3		10q25.2		
#611390	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3		2q33.1		
#614702	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10		6q13		
#614877	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B		11p11.2		
#614898	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53		8p22		
#614947	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15		15q22.31		
#615030	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56		4q25		
#615181	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11		1q42.3		
#615330	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3		1q42.13		
#615386	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14		11q13.2		
#615418	MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE; MTDPS12B		4q35.1		
#615983	BARDET-BIEDL SYNDROME 5; BBS5		2q31.1		
#615987	BARDET-BIEDL SYNDROME 10; BBS10		12q21.2		
#615989	BARDET-BIEDL SYNDROME 12; BBS12		4q27		
#615994	BARDET-BIEDL SYNDROME 17; BBS17		3p21.31		
#615995	BARDET-BIEDL SYNDROME 18; BBS18		10q25.2		
#616094	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12		8p11.21		
#616307	SENIOR-LOKEN SYNDROME 8; SLSN8		4p14		
#616413	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6		1q25.3		
#616479	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2		2p25.3		
#616541	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED		5q14.2		
#616640	EPILEPSY, PROGRESSIVE MYOCLONIC, 10; EPM10		4q21.21		
#616668	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X		15q21.1		
#616779	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2		10q26.13		
#617008	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3		10q25.1-q25.2		
#617056	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4		3q21.3		
#617070	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4; PEOB4		2p13.1		
#617143	MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20		2q12.3		
#617560	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8		10q26.3		
#617584	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25		6q21		
#617595	BIRK-LANDAU-PEREZ SYNDROME; BILAPES		4p13		
#617761	JOUBERT SYNDROME 31; JBTS31		5q23.2		
#617951	LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15		1q41		
#618564	MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL		13q34		
#618877	LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME; LEUDEN		2p22.2		
#619061	MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17; MC4DN17		14q32.33		
#176500	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1		13q14.2		
#208920	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	ATAXIA, ADULT-ONSET, WITH OCULOMOTOR APRAXIA, INCLUDED	9p21.1		
#213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1		8p11.21		
#601780	CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6		15q23		
#245200	KRABBE DISEASE		14q31.3		
#254780	MYOCLONIC EPILEPSY OF LAFORA	EPILEPSY, PROGRESSIVE MYOCLONIC, 2B, INCLUDED; EPM2B, INCLUDED	6p22.3, 6q24.3		
#278700	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA		9q22.33		
#278800	DE SANCTIS-CACCHIONE SYNDROME		10q11.23		
#607625	NIEMANN-PICK DISEASE, TYPE C2; NPC2		14q24.3		
#234500	HARTNUP DISORDER; HND		5p15.33		
#275900	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20		13q13.3		
#609981	IMMUNODEFICIENCY 54; IMD54		8q11.21		
#201100	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ		8q24.3		
#616370	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4		14q24.3		
#259730	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3		8q21.2		
#613676	SECKEL SYNDROME 4; SCKL4		13q12.12-q12.13		
#615491	SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79		4p13		
#616204	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18		4q22.1-q22.2		
#218700	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2		2q14.1		
#158600	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1		14q32.31		
#261990	ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD		11q21		
#614701	CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; CDLS4		8q24.11		
#618853	ANAUXETIC DYSPLASIA 3; ANXD3		3q13.2		
#618891	MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME; MDBH		11p15.4		
#174300	OROFACIODIGITAL SYNDROME V; OFD5		1q32.1		
#175780	BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1		13q34		
#600348	BAND HETEROTOPIA; BH		14q32.2		
#600987	CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR		15q14		
#603585	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F		6q15		
#604213	CHUDLEY-MCCULLOUGH SYNDROME; CMCS		1p13.3		
#243310	BARAITSER-WINTER SYNDROME 1; BRWS1		7p22.1		
#244450	KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS		12q24.11		
#248000	MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH		6p24.1		
#250410	RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES; RPSKA		5q12.3		
#251280	DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1; DMJDS1		5q31.3		
#254940	CAREY-FINEMAN-ZITER SYNDROME; CFZS		9q34.2		
#607317	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4		1p36.22-p36.21		
#608776	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L		11q23.1		
#612703	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7		1p33		
#613451	FRONTONASAL DYSPLASIA 2; FND2		11p11.2		
#610042	PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1		7q35-q36		
#613728	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10		3p22.1-p21.3		
#613886	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD		9q21.33		
#613970	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6		12p13.1		
#614111	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD		3p14.3		
#614230	CHROMOSOME 8q21.11 DELETION SYNDROME		8q21.11	8:72000000-74600000	
#614254	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD		9q34.3		
#614255	NESCAV SYNDROME; NESCAVS		2q37.3		
#614558	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13		12q13.13		
#614576	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L		13q14.11		
#614613	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2		5q11.2-q12.1		
#614847	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12		1p34.2		
#614863	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B		6p21.1		
#614920	PEROXISOME BIOGENESIS DISORDER 14B; PEX14B		1q21.1		
#615005	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5		9q34.3		
#615009	SCHUURS-HOEIJMAKERS SYNDROME; SHMS		11q13.1-q13.2		
#615032	AUTISM, SUSCEPTIBILITY TO, 18; AUTS18		14q11.2		
#615071	ALAZAMI SYNDROME; ALAZS		4q25		
#615075	NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV		3p22.1		
#615145	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	MICROPHTHALMIA, SYNDROMIC 15, INCLUDED; MCOPS15, INCLUDED	4q34.3-q35.1		
#615219	HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2		9p23		
#615355	NOONAN SYNDROME 8; NS8		1q22		
#615356	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18		4q35.1		
#615493	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37; MRT37		10q21.2		
#615510	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR		2q35		
#615547	SCHAAF-YANG SYNDROME; SHFYNG		15q11.2		
#615578	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18; COXPD18		10q26.11		
#615656	CHROMOSOME 15q11.2 DELETION SYNDROME		15q11.2	15:20500000-25500000	
#615668	CHROMOSOME 5q12 DELETION SYNDROME		5q12	5:59600000-67400000	
#615683	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64		10q24.1		
#615722	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS		5q15		
#615744	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19; DEE19		5q34		
#615761	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23		3p25.3		
#615807	SECKEL SYNDROME 8; SCKL8		10q21.3		
#615816	IMMUNODEFICIENCY 23; IMD23		6q14.1		
#615834	MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26		7q11.22		
#615838	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8		5q23.3-q31.1		
#615862	NEPHRONOPHTHISIS 18; NPHP18		12q22		
#615871	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24; DEE24		5p12		
#615877	MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS		4q31.3		
#615879	TATTON-BROWN-RAHMAN SYNDROME; TBRS		2p23.3		
#615937	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2		1q43-q44		
#615948	OROFACIODIGITAL SYNDROME XIV; OFD14		11q13.4		
#616080	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12		7q21.2		
#616095	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D		1p13.2		
#616127	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17		10q24.31		
#616139	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27; DEE27		12p13.1		
#616202	CEREBELLOFACIODENTAL SYNDROME; CFDS		14q32.33		
#616271	3-METHYLGLUTACONIC ACIDURIA, TYPE VII; MGCA7		11q13.4		
#616346	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31; DEE31		9q34.11		
#616364	WHITE-SUTTON SYNDROME; WHSUS		1q21.3		
#616366	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32; DEE32		1p13.3		
#616368	CHOPS SYNDROME; CHOPS		5q31.1		
#616421	MYOCLONIC-ATONIC EPILEPSY; MAE		3p25.3		
#616460	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50		15q24.1		
#616486	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES; NEDMISBA		1p34.2		
#616494	LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11		6p21.1		
#616521	MENTAL RETARDATION, AUTOSOMAL DOMINANT 39; MRD39	CHROMOSOME 2p25.3 DELETION SYNDROME, INCLUDED	2p25.3		
#616579	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40		13q34		
#616580	AU-KLINE SYNDROME; AUKS		9q21.32		
#616586	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B		10q24.1		
#616606	RING CHROMOSOME 14 SYNDROME		Chr.14		
#616638	SMITH-KINGSMORE SYNDROME; SKS		1p36.22		
#616657	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM		2p14		
#616683	LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12		11q23.3		
#616716	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5		12p13.31		
#616719	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21		11q13.1		
#616721	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N		4q24		
#616737	TAKENOUCHI-KOSAKI SYNDROME; TKS		1p36.12		
#616756	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES; SPPRS		6q16.3		
#616801	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2		2q34		
#616803	LAMB-SHAFFER SYNDROME; LAMSHF		12p12.1		
#616831	LUSCAN-LUMISH SYNDROME; LLS		3p21.31		
#616835	MEIER-GORLIN SYNDROME 6; MGORS6		6p22.3		
#616875	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR		1p36.13		
#616887	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52; MRT52		2q11.2		
#616898	CHROMOSOME 15q14 DELETION SYNDROME		15q14	15:33400000-39800000	
#616902	CHROMOSOME 11p13 DELETION SYNDROME, DISTAL		11p13	11:31000000-36400000	
#616910	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3		2q31.1		
#616911	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4		10q23.33		
#616939	CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION; COCPMR		1p21.2		
#616944	MENTAL RETARDATION, AUTOSOMAL DOMINANT 41; MRD41		3q26.32		
#616948	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22; SCAR22		2q11.2		
#616949	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23		6p22.3		
#616973	MENTAL RETARDATION, AUTOSOMAL DOMINANT 42; MRD42		1p36.33		
#616977	MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43		6q24.2		
#617011	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR		15q22.31		
#617013	HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2		8p21.3		
#617026	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F; PCH2F		1q25.3		
#617028	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54; MRT54		3q26.2-q26.3		
#617044	SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD		3p21.1		
#617061	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY; MRD44		5p15.2		
#617093	GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH		9q22.31		
#617101	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN		2p16.1		
#617107	THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS		11q13.1		
#617113	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43; DEE43		15q12		
#617119	BARDET-BIEDL SYNDROME 20; BBS20		9p21.2		
#617125	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56; MRT56		14q31.3		
#617126	ALAZAMI-YUAN SYNDROME; ALYUS		7q22.1		
#617132	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44; DEE44		3q22.1		
#617137	FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2		6q15		
#617159	SIFRIM-HITZ-WEISS SYNDROME; SIHIWES		12p13.31		
#617173	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA		15q21.2		
#617182	LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI		15q21.2		
#617183	HAREL-YOON SYNDROME; HAYOS		1p36.33		
#617190	SHASHI-PENA SYNDROME; SHAPNS		2p23.3		
#617207	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO		1q42.3		
#617237	IMMUNODEFICIENCY 49; IMD49		14q32.2		
#617244	FANCONI ANEMIA, COMPLEMENTATION GROUP R; FANCR		15q15.1		
#617255	LISSENCEPHALY 8; LIS8		12q21.32		
#617260	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF		3q21.2		
#617268	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL		2q32.3		
#617290	EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D		8p11.23		
#617296	SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO		2p25.1		
#617302	OPTIC ATROPHY 11; OPA11		10p12.1		
#617308	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6		3p14.3		
#617330	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS		10q26.3		
#617333	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP		3p25.3		
#617360	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD		7p14.1		
#617384	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4		10q21.3		
#617396	ANAUXETIC DYSPLASIA 2; ANXD2		8q22.2		
#617412	BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD		5q14.2		
#617425	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA		8p21.1		
#617432	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60; MRT60		1p13.3		
#617435	LOPES-MACIEL-RODAN SYNDROME; LOMARS		4p16.3		
#617452	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA		8q21.3		
#617520	MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18		4q21.23		
#617523	NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM		1q22		
#617532	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF		1p36.23		
#617537	RAHMAN SYNDROME; RMNS		6p22.2		
#617557	GABRIELE-DE VRIES SYNDROME; GADEVS		14q32.2		
#617561	COHEN-GIBSON SYNDROME; COGIS		11q14.2		
#617601	MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46		6q13		
#617616	SKRABAN-DEARDORFF SYNDROME; SKDEAS		1q42.11-q42.12		
#617622	JOUBERT SYNDROME 30; JBTS30		2q37.1		
#617635	MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47		3q22.3		
#617660	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1		2p21		
#617665	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 56; DEE56		7q11.23		
#617675	MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT		1q22		
#617682	PILAROWSKI-BJORNSSON SYNDROME; PILBOS		5q15-q21		
#617695	PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11		3q12.1-q12.2		
#617709	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS		1p13.3		
#617710	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS		1p12		
#617711	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1		4q24		
#617729	GALLOWAY-MOWAT SYNDROME 3; GAMOS3		14q11.2		
#617744	IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH		2q31.2		
#617751	MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48		7p22.1		
#617752	CLARK-BARAITSER SYNDROME; CLABARS		2q36.3		
#617757	JOUBERT SYNDROME 32; JBTS32		10q24.32		
#617762	LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO		11q13.5		
#617763	SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF		9q34.12		
#617768	KLEEFSTRA SYNDROME 2; KLEFS2		7q36.1		
#617773	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61		9p13.3		
#617787	MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50		4q31.1		
#617788	MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51		11q13.2		
#617796	MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52		1q22		
#617798	MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53		5q32		
#617799	MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54		7p13		
#617802	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA		6p21.33		
#617804	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL		3p21.31		
#617810	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15		8q24.3		
#617816	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16		1q24.3		
#617820	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR		9q34.3		
#617822	ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS		4q27		
#617829	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2		5q34		
#617830	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 58; DEE58		9q21.33		
#617831	MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55		6q22.1		
#617836	DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM		1p36.11		
#617862	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA		14q21.1		
#617864	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA		11q22.3		
#617865	NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA		5q12.1		
#617873	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35		1p34.2		
#617885	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19		2p23.3		
#617899	LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14		13q13.3		
#617903	NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS		9q22.33		
#617904	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 59; DEE59		9q22.33		
#617914	MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20		1q32.1		
#617915	HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS		4p16.3		
#617929	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60		6p21.1		
#617930	CHROMOSOME 1p35 DELETION SYNDROME		1p35	1:27600000-34300000	
#617931	SPINOCEREBELLAR ATAXIA 47; SCA47		1p35.2		
#617933	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61		7q21.12		
#617950	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36		9q34.3		
#617954	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6		7q22.1		
#617964	LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16		7p21.3		
#617976	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63		4p16.3		
#617982	VERVERI-BRADY SYNDROME; VERBRAS		3p21.31		
#617983	MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21		12p13.31		
#617985	MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23		2q11.2		
#617988	JABERI-ELAHI SYNDROME; JABELS		6p21.1		
#617991	CHUNG-JANSEN SYNDROME; CHUJANS		6q14.1		
#618004	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64		8p21.3		
#618005	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1		14q23.3		
#618006	LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17		7p22.1		
#618012	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3		3q13.31		
#618027	COFFIN-SIRIS SYNDROME 7; CSS7		11q13.1		
#618056	NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS		7p22.3		
#618060	INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA		15q22.2		
#618067	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66		14q32.33		
#618076	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG		1q23.3		
#618088	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS		14q24.3		
#618089	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA		2p16.3		
#618092	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA		14q32.2		
#618095	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63		5q32		
#618103	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64		15q24.3		
#618106	MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58		9q34.11		
#618109	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65		1q32.1		
#618174	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9		2p12		
#618195	INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP		15q24.3		
#618265	ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID		4q24		
#618280	CARDIAC-UROGENITAL SYNDROME; CUGS		11q12.2		
#618286	MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID		9p23-p22		
#618330	GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI		7q22.1		
#618402	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70		3q25.32		
#618479	CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG		13q13.3		
#618493	HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA		3p21.31		
#618506	COFFIN-SIRIS SYNDROME 10; CSS10		6p22.3		
#618625	ROTHMUND-THOMSON SYNDROME, TYPE 1; RTS1		2q13		
#618652	NEUROOCULOCARDIOGENITOURINARY SYNDROME; NOCGUS		10p15.3		
#618658	ZIMMERMANN-LABAND SYNDROME 3; ZLS3		1q21.3		
#618725	INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES; IDDBCS		11p11.2		
#618744	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83; DEE83		2p15		
#618761	CATIFA SYNDROME; CATIFA		9p24.1		
#618804	SANDESTIG-STEFANOVA SYNDROME; SANDSTEF		9q34.11		
#618820	GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME; GUBS		12q21.2-q21.3		
#618846	DIETS-JONGMANS SYNDROME; DIJOS		5q31.2		
#618973	NEURODEGENERATION, INFANTILE-ONSET, BIOTIN-RESPONSIVE; NERIB		2p23.3		
#618998	IMMUNE DYSREGULATION AND SYSTEMIC HYPERINFLAMMATION SYNDROME; IMDYSHI		1q25.1		
#222470	TRICHOHEPATOENTERIC SYNDROME 1; THES1		5q15		
#608804	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2		1q42.13		
#236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1		9q34.13		
#253280	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3		1p34.1		
#607417	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2		3p26.2		
#613150	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2		14q24.3		
#100300	ADAMS-OLIVER SYNDROME 1; AOS1	APLASIA CUTIS CONGENITA, CONGENITAL HEART DEFECT, AND FRONTONASAL CYSTS, INCLUDED	3q13.32-q13.33		
#101200	APERT SYNDROME	APERT-CROUZON DISEASE, INCLUDED	10q26.13		
#101600	PFEIFFER SYNDROME	CRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	8p11.23, 10q26.13		
#105830	ANGELMAN SYNDROME; AS	ANGELMAN SYNDROME CHROMOSOME REGION, INCLUDED; ANCR, INCLUDED	15q11.2		
#109400	BASAL CELL NEVUS SYNDROME; BCNS		1p34.1, 9q22.32, 10q24.32		
#113620	BRANCHIOOCULOFACIAL SYNDROME; BOFS		6p24.3		
#115150	CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1		7q34		
#117550	SOTOS SYNDROME 1; SOTOS1		5q35.3		
#120330	PAPILLORENAL SYNDROME; PAPRS		10q24.31		
#120433	COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1		11q22.1		
#122470	CORNELIA DE LANGE SYNDROME 1; CDLS1		5p13.2		
#123500	CROUZON SYNDROME		10q26.13		
#124000	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1		2q35		
#124200	DARIER-WHITE DISEASE; DAR	DARIER DISEASE, ACRAL HEMORRHAGIC TYPE, INCLUDED	12q24.11		
#125800	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL		12q13.12		
#220120	D-GLYCERIC ACIDURIA		3p21.2		
#221750	PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3		9q34.3		
#222300	WOLFRAM SYNDROME 1; WFS1		4p16.1		
#222730	DICARBOXYLIC AMINOACIDURIA; DCBXA		9p24.2		
#222748	DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD		8q22.3		
#222765	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2		1q42.2		
#224050	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1		9p24.2		
#224230	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1		15q14		
#224690	MEIER-GORLIN SYNDROME 1; MGORS1		1p32.3		
#225250	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5		5q35.1		
#605309	MACROCEPHALY/AUTISM SYNDROME		10q23.31		
#609033	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1		1q32.3		
#609152	HYPERTHYROIDISM, NONAUTOIMMUNE		14q31.1		
#133540	COCKAYNE SYNDROME B; CSB		10q11.23		
#135100	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP		2q24.1		
#135500	ZIMMERMANN-LABAND SYNDROME 1; ZLS1		1q32.2		
#135900	COFFIN-SIRIS SYNDROME 1; CSS1		6q25.3		
#136630	MENTAL RETARDATION, FRA12A TYPE		12q13.12		
#136760	FRONTONASAL DYSPLASIA 1; FND1		1p13.3		
#142945	HOLOPROSENCEPHALY 3; HPE3		7q36.3		
#146000	HYPOCHONDROPLASIA; HCH		4p16.3		
#147791	JACOBSEN SYNDROME; JBS		11q23.3-q25	11:114600000-135086622	
#147920	KABUKI SYNDROME 1; KABUK1		12q13.12		
#148820	WAARDENBURG SYNDROME, TYPE 3; WS3		2q36.1		
#150230	TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2		8q24.11-q24.13	8:116700000-126300000	
#150250	LARSEN SYNDROME; LRS		3p14.3		
#151050	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD		8q22.1		
#151100	LEOPARD SYNDROME 1; LPRD1		12q24.13		
#152950	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR		10q23.33		
#156200	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1	CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	2q23.1		
#156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1		6p21.33		
#157170	HOLOPROSENCEPHALY 2; HPE2		2p21		
#158170	CHROMOSOME 9p DELETION SYNDROME		9p		
#158350	COWDEN SYNDROME 1; CWS1	LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED	10q23.31		
#158900	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED	4q35	4:182300000-190214555	
#163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM		1p13.2, 11p15.5, 12p12.1		
#163950	NOONAN SYNDROME 1; NS1	PTERYGIUM COLLI SYNDROME, INCLUDED	12q24.13		
#164200	OCULODENTODIGITAL DYSPLASIA; ODDD		6q22.31		
#164280	FEINGOLD SYNDROME 1; FGLDS1		2p24.3		
#175700	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS		7p14.1		
#176270	PRADER-WILLI SYNDROME; PWS	PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED	15q11.2, 15q11.2		
#176920	PROTEUS SYNDROME	ELATTOPROTEUS SYNDROME, INCLUDED	14q32.33		
#180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1		3p14.3		
#182212	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS		1p36.33-p36.32		
#182600	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A		14q22.1		
#185300	STURGE-WEBER SYNDROME; SWS		9q21.2		
#187600	THANATOPHORIC DYSPLASIA, TYPE I; TD1		4p16.3		
#188025	THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT		11q23	11:110600000-121300000	
#191100	TUBEROUS SCLEROSIS 1; TSC1		9q34.13		
#194050	WILLIAMS-BEUREN SYNDROME; WBS		7q11.23	7:72700000-77900000	
#194072	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR		11p13	11:31000000-36400000	
#194190	WOLF-HIRSCHHORN SYNDROME; WHS		4p16.3		
#200990	ACROCALLOSAL SYNDROME; ACLS	JOUBERT SYNDROME 12, INCLUDED; JBTS12, INCLUDED	15q26.1		
#202370	PEROXISOME BIOGENESIS DISORDER 2B; PBD2B		12p13.31		
#203650	ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1		3q26.3-q27.3	3:171200000-188200000	
#203750	ALPHA-METHYLACETOACETIC ACIDURIA		11q22.3		
#204750	2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD		10p14		
#206700	GILLESPIE SYNDROME; GLSP		3p26.1		
#206920	MICROPHTHALMIA WITH LIMB ANOMALIES; MLA		14q24.2		
#207410	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2		10q26.13		
#207800	ARGININEMIA		6q23.2		
#207900	ARGININOSUCCINIC ACIDURIA		7q11.21		
#209885	BARBER-SAY SYNDROME; BBRSAY		2q37.3		
#209900	BARDET-BIEDL SYNDROME 1; BBS1		1p35.2, 3q11.2, 11q13.2		
#210000	BEHR SYNDROME; BEHRS		3q29		
#210200	3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D		3q27.1		
#210210	3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D		5q13.2		
#210600	SECKEL SYNDROME 1; SCKL1		3q23		
#210710	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1		2q14.2		
#210900	BLOOM SYNDROME; BLM		15q26.1		
#212066	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A		14q21.3		
#212112	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM		1q22		
#212720	MARTSOLF SYNDROME		1q41		
#213300	JOUBERT SYNDROME 1; JBTS1		9q34.3		
#213700	CEREBROTENDINOUS XANTHOMATOSIS; CTX		2q35		
#213980	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME; CFSMR		1q24.1		
#214100	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A	PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 1, INCLUDED; CG1, INCLUDED	7q21.2		
#214110	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 2, INCLUDED; CG2, INCLUDED	12p13.31		
#214150	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1		10q11.23		
#214450	GRISCELLI SYNDROME, TYPE 1; GS1		15q21.2		
#214800	CHARGE SYNDROME		7q21.11, 8q12.2		
#215100	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1		6q23.3		
#215700	CITRULLINEMIA, CLASSIC		9q34.11		
#216360	COACH SYNDROME		4p15.32, 8q22.1, 16q12.2		
#216400	COCKAYNE SYNDROME A; CSA		5q12.1		
#216550	COHEN SYNDROME; COH1		8q22.2		
#218000	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN		15q14		
#218040	COSTELLO SYNDROME; CSTLO	MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES, INCLUDED; CMEMS, INCLUDED	11p15.5		
#218340	TEMTAMY SYNDROME; TEMTYS		12p13.31		
#218600	BALLER-GEROLD SYNDROME; BGS		8q24.3		
#219000	FRASER SYNDROME 1; FRASRS1		4q21.21		
#219200	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A		12q24.31		
#219500	CYSTATHIONINURIA		1p31.1		
#600118	WARBURG MICRO SYNDROME 1; WARBM1		2q21.3		
#600430	CHROMOSOME 2q37 DELETION SYNDROME		2q37	2:230100000-242193529	
#600721	D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1		2q37.3		
#601005	TIMOTHY SYNDROME; TS		12p13.33		
#601068	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1		8q24.11-q24.12		
#601186	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 8, INCLUDED; MCOPCB8, INCLUDED	15q24.1		
#601358	NICOLAIDES-BARAITSER SYNDROME; NCBRS		9p24.3		
#601678	BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1		15q21.1		
#601776	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1		15q15.1		
#601815	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD		1p12		
#602032	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4		12q13.13		
#602481	MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	MIGRAINE, FAMILIAL BASILAR, INCLUDED	1q23.2		
#602485	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3		7p13		
#602501	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP		3q26.32		
#602522	BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4A	SENSORINEURAL DEAFNESS WITH MILD RENAL DYSFUNCTION, INCLUDED	1p32.3		
#602531	GRANGE SYNDROME; GRNG		1q22		
#602668	MYOTONIC DYSTROPHY 2; DM2		3q21.3		
#602849	MUENKE SYNDROME; MNKES		4p16.3		
#603513	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1		2q31.1		
#603671	ACROMELIC FRONTONASAL DYSOSTOSIS; AFND		5q12.1		
#604278	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION		4q13.3		
#604292	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3		3q28		
#604321	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4		15q15.1		
#604369	SALLA DISEASE; SD		6q13		
#604804	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3		9q33.2		
#605130	WIEDEMANN-STEINER SYNDROME; WDSTS		11q23.3		
#225500	ELLIS-VAN CREVELD SYNDROME; EVC		4p16.2, 4p16.2		
#227645	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC		9q22.32		
#227646	FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2		3p25.3		
#228000	FARBER LIPOGRANULOMATOSIS; FRBRL		8p22		
#229600	FRUCTOSE INTOLERANCE, HEREDITARY; HFI		9q31.1		
#230000	FUCOSIDOSIS		1p36.11		
#230400	GALACTOSEMIA I; GALAC1	GALACTOSEMIA, DUARTE VARIANT, INCLUDED	9p13.3		
#230500	GM1-GANGLIOSIDOSIS, TYPE I	GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED	3p22.3		
#230650	GM1-GANGLIOSIDOSIS, TYPE III		3p22.3		
#230740	GAPO SYNDROME; GAPOS		2p13.3		
#231070	GERODERMA OSTEODYSPLASTICUM; GO		1q24.2		
#231550	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS	ACHALASIA-ALACRIMA SYNDROME, INCLUDED	12q13.13		
#233910	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE, INCLUDED	14q22.2		
#235730	MOWAT-WILSON SYNDROME; MOWS		2q22.3		
#235800	HISTIDINEMIA		12q23.1		
#236600	HYDROCEPHALUS, CONGENITAL, 1; HYC1		14q32.11-q32.12		
#236792	L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA		14q21.3		
#236800	HYDROXYKYNURENINURIA		2q22.2		
#237300	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO		2q34		
#238970	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; HHHS		13q14.11		
#239300	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1		1p36.11		
#239510	HYPERPROLINEMIA, TYPE II; HYRPRO2		1p36.13		
#239850	CANTU SYNDROME		12p12.1		
#240800	HYPOGLYCEMIA, LEUCINE-INDUCED; LIH		11p15.1		
#241200	BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2		11q24.3		
#241410	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS		1q42.3		
#243800	JOHANSON-BLIZZARD SYNDROME; JBS		15q15.2		
#245150	KEUTEL SYNDROME; KTLS		12p12.3		
#245348	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD		11q23.1		
#245349	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD		11p13		
#245400	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9		2p11.2		
#246560	SPLIT-HAND/FOOT MALFORMATION 3; SHFM3		10q24	10:95300000-104000000	
#248510	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB		4q24		
#248600	MAPLE SYRUP URINE DISEASE; MSUD	MAPLE SYRUP URINE DISEASE, CLASSIC, INCLUDED	1p21.2, 6q14.1, 19q13.2		
#248800	MARINESCO-SJOGREN SYNDROME; MSS		5q31.2		
#249500	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1		4q26		
#250850	METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY		10q22.3		
#251200	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1		8p23.1		
#251260	NIJMEGEN BREAKAGE SYNDROME; NBS	BERLIN BREAKAGE SYNDROME, INCLUDED; BBS, INCLUDED	8q21.3		
#251300	GALLOWAY-MOWAT SYNDROME 1; GAMOS1		15q25.2		
#252600	MUCOLIPIDOSIS III ALPHA/BETA	MUCOLIPIDOSIS III ALPHA/BETA, ATYPICAL, INCLUDED	12q23.2		
#252930	MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C		8p11.2-p11.1		
#252940	MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D		12q14.3		
#253220	MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7		7q11.21		
#253800	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4		9q31.2		
#255200	MYOPATHY, CENTRONUCLEAR, 2; CNM2		2q14.3		
#255800	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1		1p36.12		
#255995	MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB		12q13.3		
#256000	LEIGH SYNDROME; LS	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED	5p15.33		
#256040	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1, DIGENIC, INCLUDED	6p21.32		
#256450	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1		11p15.1		
#256550	NEURAMINIDASE DEFICIENCY	SIALIDOSIS, TYPE I, INCLUDED	6p21.33		
#256800	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA		1q23.1		
#257200	NIEMANN-PICK DISEASE, TYPE A	NIEMANN-PICK DISEASE, INTERMEDIATE, PROTRACTED NEUROVISCERAL, INCLUDED	11p15.4		
#257300	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1		15q15.1		
#257920	3MC SYNDROME 1; 3MC1		3q27.3		
#259050	PRIMROSE SYNDROME; PRIMS		3q13.31		
#259770	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG		11q13.2		
#260400	SHWACHMAN-DIAMOND SYNDROME 1; SDS1		7q11.21		
#261600	PHENYLKETONURIA; PKU	HYPERPHENYLALANINEMIA, NON-PKU MILD, INCLUDED	12q23.2		
#261630	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C		4p15.32		
#261640	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, DUE TO PARTIAL PTS DEFICIENCY, INCLUDED	11q23.1		
#262000	BJORNSTAD SYNDROME; BJS		2q35		
#264090	WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS		10q22.3		
#265050	3MC SYNDROME 2; 3MC2		2p25.3		
#266100	EPILEPSY, PYRIDOXINE-DEPENDENT; EPD		5q23.2		
#266150	PYRUVATE CARBOXYLASE DEFICIENCY		11q13.2		
#266265	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C		11p11.2		
#268300	ROBERTS SYNDROME; RBS		8p21.1		
#268310	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1; RRS1	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OF PHALANGES AND METACARPALS/METATARSALS, INCLUDED	9q22.31		
#268400	ROTHMUND-THOMSON SYNDROME, TYPE 2; RTS2		8q24.3		
#269700	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2		11q12.3		
#270400	SMITH-LEMLI-OPITZ SYNDROME; SLOS		11q13.4		
#270450	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO, DUE TO INCREASED BINDING PROTEIN, INCLUDED	15q26.3		
#270550	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS		13q12.12		
#271245	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7		10q24.31		
#271510	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP		8q24.3		
#271980	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD		6p22.3		
#272200	MULTIPLE SULFATASE DEFICIENCY; MSD		3p26.1		
#272440	FILIPPI SYNDROME; FLPIS		2q14.1		
#274000	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR		1q21.1		
#274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	5-FLUOROURACIL TOXICITY, INCLUDED	1p21.3		
#274700	THYROID DYSHORMONOGENESIS 3; TDH3		8q24.22		
#274800	THYROID DYSHORMONOGENESIS 4; TDH4		6q25.1		
#274900	THYROID DYSHORMONOGENESIS 5; TDH5		15q21.1		
#275100	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4	THYROTROPIN, BIOLOGICALLY INACTIVE, INCLUDED	1p13.2		
#275630	CHANARIN-DORFMAN SYNDROME; CDS		3p21.33		
#276710	TYROSINEMIA, TYPE III; TYRSN3		12q24.31		
#276880	UROCANASE DEFICIENCY; UROCD		3q21.3		
#277170	OROFACIODIGITAL SYNDROME VI; OFD6		5p13.2		
#277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC, INCLUDED	1p34.1, 1p34.1		
#277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD	HOMOCYSTINURIA, cblD TYPE, VARIANT 1, INCLUDED	2q23.2		
#277590	WEAVER SYNDROME; WVS		7q36.1		
#605899	GLYCINE ENCEPHALOPATHY; GCE	HYPERGLYCINEMIA, TRANSIENT NEONATAL, INCLUDED; TNH, INCLUDED	3p21.31, 9p24.1, 16q23.2		
#606407	HYPOTONIA-CYSTINURIA SYNDROME	HOMOZYGOUS 2p21 DELETION SYNDROME, INCLUDED	2p21	2:41500000-47500000	
#606762	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6		10q23.2		
#606777	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1	GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	1p34.2		
#606812	FUMARASE DEFICIENCY; FMRD		1q43		
#607095	ANAUXETIC DYSPLASIA 1; ANXD1		9p13.3		
#607330	LATHOSTEROLOSIS; LATHOS		11q23.3-q24.1		
#607341	FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2	FOCAL CORTICAL DYSPLASIA, TYPE IIA, INCLUDED; FCORD2A, INCLUDED	1p36.22, 9q34.13, 16p13.3		
#607426	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1		4q21.23		
#607596	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A		14q32.2		
#607721	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1		10q25.2		
#607855	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO PARTIAL LAMA2 DEFICIENCY, INCLUDED	6q22.33		
#607872	CHROMOSOME 1p36 DELETION SYNDROME		1p36		
#607906	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I		9q22.33		
#608033	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3		2q13		
#608091	JOUBERT SYNDROME 2; JBTS2		11q12.2		
#608093	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J		11q23.3		
#608233	HERMANSKY-PUDLAK SYNDROME 2; HPS2		5q14.1		
#608328	WEILL-MARCHESANI SYNDROME 2; WMS2		15q21.1		
#608393	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6		13q12.12-q12.13		
#608629	JOUBERT SYNDROME 3; JBTS3		6q23.3		
#608636	CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	AUTISM, SUSCEPTIBILITY TO, 4, INCLUDED; AUTS4, INCLUDED	15q11	15:19000000-25500000	
#608654	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5		1p13.2		
#608688	AICA-RIBOSURIA DUE TO ATIC DEFICIENCY		2q35		
#608716	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5		1q31.3		
#608747	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY		12q23.2		
#608782	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD		8q22.1		
#608885	STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN		1p34.2		
#611553	NOONAN SYNDROME 5; NS5		3p25.2		
#611603	LISSENCEPHALY 3; LIS3		12q13.12		
#611726	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3		7q11.21		
#611816	TEMPLE-BARAITSER SYNDROME; TMBTS		1q32.2		
#612015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N		3p21.1		
#612016	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4		1q42.13		
#612073	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5		13q14.2		
#612075	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A	MITOCHONDRIAL DNA DEPLETION SYNDROME 8B (MNGIE TYPE), INCLUDED; MTDPS8B, INCLUDED	8q22.3		
#612079	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES		7q32.1		
#612233	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4		2q33.1		
#612285	JOUBERT SYNDROME 9; JBTS9	JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	4p15.32		
#612291	JOUBERT SYNDROME 8; JBTS8		3q11.1-q11.2		
#612313	GLASS SYNDROME; GLASS		2q33.1		
#612337	MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	CHROMOSOME 1q43-q44 DELETION SYNDROME, INCLUDED	1q44		
#612379	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q		4q12		
#612447	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION		11q23.2		
#612474	CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB		1q21.1	1:143200000-147500000	
#612475	CHROMOSOME 1q21.1 DUPLICATION SYNDROME		1q21.1	1:143200000-147500000	
#612513	CHROMOSOME 2p16.1-p15 DELETION SYNDROME		2p16.1-p15	2:54700000-63900000	
#612530	CHROMOSOME 1q41-q42 DELETION SYNDROME		1q41-q42	1:214400000-236400000	
#612582	CHROMOSOME 6pter-p24 DELETION SYNDROME		6pter-p24		
#612621	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5		6p21.32		
#612626	CHROMOSOME 15q26-qter DELETION SYNDROME		15q26-qter	15:88500000-101991189	
#612713	KAHRIZI SYNDROME; KHRZ		4q12		
#612716	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY		2p13.2		
#612718	CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3		15q21.1		
#612780	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES		1q23.2		
#612936	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50		7q22.1		
#613038	PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1		3p11.2		
#613068	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY		11q13.4		
#613090	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B		1p36.13, 1p36.13		
#613151	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3; MDDGB3		1p34.1		
#613155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL IMPAIRMENT), TYPE B, 1; MDDGB1		9q34.13		
#613156	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2; MDDGB2		14q24.3		
#613162	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45		10q24.32-q24.33		
#613174	CHROMOSOME 5p13 DUPLICATION SYNDROME		5p13	5:28900000-42500000	
#613179	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY		14q11.2		
#613192	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13		8q24.3		
#613227	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3		8q12.1		
#613254	TUBEROUS SCLEROSIS 2; TSC2	TSC2 ANGIOMYOLIPOMAS, RENAL, MODIFIER OF, INCLUDED	12q15, 16p13.3		
#613398	WARSAW BREAKAGE SYNDROME; WABS		12p11.21		
#613443	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; MRD20	CHROMOSOME 5q14.3 DELETION SYNDROME, PROXIMAL, INCLUDED	5q14.3		
#613454	RETT SYNDROME, CONGENITAL VARIANT		14q12		
#613457	CHROMOSOME 14q11-q22 DELETION SYNDROME		14q11-q22	14:17200000-57600000	
#613477	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5; DEE5		9q34.11		
#609192	LOEYS-DIETZ SYNDROME 1; LDS1		9q22.33		
#609195	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26		12q13.3		
#609307	SPINOCEREBELLAR ATAXIA 27; SCA27		13q33.1		
#609308	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1		9q34.13		
#609313	MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA; MEDNIK		7q22.1		
#609425	CHROMOSOME 3q29 DELETION SYNDROME		3q29	3:192600000-198295559	
#609460	GOLDBERG-SHPRINTZEN SYNDROME; GOSHS		10q22.1		
#609625	CHROMOSOME 10q26 DELETION SYNDROME		10q26	10:117300000-133797422	
#609637	HOLOPROSENCEPHALY 5; HPE5		13q32.3		
#609975	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4		4q25		
#610156	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS		9q34.3		
#610168	LOEYS-DIETZ SYNDROME 2; LDS2		3p24.1		
#610188	JOUBERT SYNDROME 5; JBTS5		12q21.32		
#610198	3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5		3q26.33		
#610253	KLEEFSTRA SYNDROME 1; KLEFS1		9q34.3		
#610442	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG		9q22.33		
#610474	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS		4p16.3		
#610532	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5		7p15.3		
#610623	CATARACT 11, MULTIPLE TYPES; CTRCT11	CATARACT 11 WITH MICROPHTHALMIA AND NEURODEVELOPMENTAL ABNORMALITIES, INCLUDED	10q24.32		
#610651	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME, INCLUDED	2q14.3		
#610688	JOUBERT SYNDROME 6; JBTS6		8q22.1		
#611090	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12		1p34.1		
#611091	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5		5p15.31		
#611092	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6		6q16.3		
#611093	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7		8p22		
#611225	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18		8p11.23		
#613612	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I		7q22.3		
#613670	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES		3p13		
#613671	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS		6q21		
#613744	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51		15q21.2		
#613811	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D		4p15.2		
#613818	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9		3p21.31		
#613823	SECKEL SYNDROME 5; SCKL5		15q21.1		
#613884	CHROMOSOME 13q14 DELETION SYNDROME		13q14	13:39500000-54700000	
#613926	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B		11q24.2		
#613987	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2		5q35.3		
#614023	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD		7p11.2		
#614066	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47		1p13.2		
#614067	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52		14q12		
#614069	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2		6q21		
#614113	MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2		9p24		
#614114	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2		11q21		
#614202	RAFIQ SYNDROME; RAFQS		9q34.3		
#614222	WARBURG MICRO SYNDROME 3; WARBM3		10p12.1		
#614225	WARBURG MICRO SYNDROME 2; WARBM2		1q41		
#614249	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18		6q23.2		
#614325	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2		2p16.3		
#614326	FEINGOLD SYNDROME 2; FGLDS2		13q31.3		
#614424	JOUBERT SYNDROME 14; JBTS14		2q33.1		
#614457	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR		6q14.1		
#614464	JOUBERT SYNDROME 15; JBTS15	JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	7q32.2		
#614499	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34		12q22		
#614563	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13		14q32.31		
#614607	COFFIN-SIRIS SYNDROME 2; CSS2	CHROMOSOME 1p36.11 DUPLICATION SYNDROME, INCLUDED	1p36.11		
#614643	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7		7p21.2		
#614651	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2		10p12.1		
#614673	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8		4q12		
#614728	SECKEL SYNDROME 6; SCKL6		3q22.2		
#614739	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL		6q25.3		
#614815	JOUBERT SYNDROME 18; JBTS18		10q24.1		
#614831	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13		6q24.3		
#614839	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10		12q13.3		
#614851	SECKEL SYNDROME 7; SCKL7		14q22.1		
#614866	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A	PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 5, INCLUDED; CG5, INCLUDED	8q21.13		
#615006	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 15; DEE15		1p34.1		
#615033	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54		8p11.23		
#615159	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4		5q31.1		
#615268	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4		13q12.13		
#615278	CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2		12p12.1		
#615281	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL		2q21.3		
#615328	SHAHEEN SYNDROME; SHNS		13q14.11		
#615350	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14		3p21.31		
#615351	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14; MDDGB14		3p21.31		
#615352	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14		3p21.31		
#615369	EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC		15q26.1		
#615516	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38		15q13.1		
#615524	MICROPHTHALMIA, SYNDROMIC 12; MCOPS12		3p24.2		
#615541	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39		8p12		
#615553	ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES; AMRS		1p21.2		
#615596	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W		11q24.2		
#615597	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X		3p23		
#615599	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40		8q24.12		
#615630	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10		2p23.3		
#615636	JOUBERT SYNDROME 21; JBTS21		8q13.1-q13.2		
#615703	MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF		3q29		
#615817	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43		12q23.3		
#615829	XIA-GIBBS SYNDROME; XIGIS		1p36.1-p35.3		
#615846	AICARDI-GOUTIERES SYNDROME 7; AGS7		2q24.2		
#615866	COFFIN-SIRIS SYNDROME 9; CSS9		2p25.2		
#615982	BARDET-BIEDL SYNDROME 4; BBS4		15q24.1		
#615984	BARDET-BIEDL SYNDROME 7; BBS7		4q27		
#615986	BARDET-BIEDL SYNDROME 9; BBS9		7p14.3		
#615991	BARDET-BIEDL SYNDROME 14; BBS14		8q22.1, 12q21.32		
#616033	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1		4q23		
#616083	MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30		10p15.3		
#616113	POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS		15q21.2		
#616116	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46; MRT46		5q33.1		
#616140	LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9		5q34		
#616154	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD		11p15.3		
#616171	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2		4q28.1		
#616222	TEMPLE SYNDROME		14q32	14:89300000-107043718	
#616269	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48		1p13.3		
#616402	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14		1p21.2		
#616418	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1; HOMGSMR1		10q24.32		
#616455	ZIMMERMANN-LABAND SYNDROME 2; ZLS2		8p21.3		
#616482	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN		4p16.3		
#616577	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS		4q28.1		
#616592	KOSAKI OVERGROWTH SYNDROME; KOGS		5q32		
#616651	ROIFMAN SYNDROME; RFMN		2q14.2		
#616732	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA10		6q21		
#616817	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2; MSSGM2		1q32.1		
#616819	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA		10p13		
#616834	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD		4q32.3		
#616943	TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6		8p12		
#616981	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37; DEE37		9q31.3		
#617051	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55; MRT55		11q24.2		
#617065	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40; DEE40		4p12		
#617105	DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41; DEE41		11p13		
#617164	SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD		11q23.3		
#617323	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59; MRT59		8q21.13		
#617507	PEHO-LIKE SYNDROME; PEHOL		2p16.1		
#617527	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA		9p21.2		
#617780	COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH		14q23.3		







